Description
Difosfocin (Citicoline) Solution for Injections 1000 mg/4 ml. 4 ml. Ampoules №3
Ingredients:
Each 4 ml ampoule contains 1000 mg of Citicoline.
Mechanism of Action:
Citicoline, the active ingredient in Difosfocin, exerts its effects by promoting neuroprotection and enhancing cognitive function. It acts by increasing phospholipid synthesis in neuronal membranes, thereby supporting brain health and function.
Pharmacological Properties:
Difosfocin possesses neuroprotective properties and aids in improving cognitive function. Citicoline, the key component, contributes to enhanced brain metabolism, reduced neuronal damage, and increased neuroplasticity.
Indications for Use:
Difosfocin is indicated for the treatment of acute ischemic stroke, traumatic brain injury, and cognitive disorders of vascular origin.
Contraindications:
Use of Difosfocin is contraindicated in patients with a known hypersensitivity to Citicoline or any other component of the formulation.
Side Effects:
Common side effects of Difosfocin may include gastrointestinal disturbances, allergic reactions, and transient changes in blood pressure. Patients should report any adverse effects to their healthcare provider.
Usage Instructions:
The recommended dosage of Difosfocin is 1000 mg (1 ampoule) per day, to be administered via intramuscular or intravenous injection under the supervision of a healthcare professional. Aseptic techniques should be followed during administration.
Benefits Compared to Analogues:
Difosfocin offers superior neuroprotective and cognitive-enhancing effects compared to other similar medications. Its mechanism of action and proven efficacy make it a preferred choice in the management of acute ischemic stroke and traumatic brain injury.
Suitable Patient Groups:
Difosfocin is suitable for adult patients suffering from acute ischemic stroke, traumatic brain injury, or cognitive disorders of vascular origin. It is not recommended for use in pediatric or elderly populations without proper medical supervision.
Storage and Shelf Life:
Difosfocin should be stored according to the manufacturer’s instructions, away from light and moisture, at controlled room temperature. The shelf life of the product should be checked before use, and expired ampoules should be discarded appropriately.
Packaging Description:
Difosfocin is supplied in 4 ml ampoules, with each box containing 3 ampoules. The packaging is designed to maintain the sterility and integrity of the product until use.
Clinical Evidence and Proven Effectiveness:
Clinical studies have shown that Citicoline, the active ingredient in Difosfocin, significantly improves neurological outcomes in patients with acute ischemic stroke and traumatic brain injury. Its neuroprotective and cognitive-enhancing effects have been well-documented, making it a valuable therapeutic option in neurology and rehabilitation.
